Farmave financials
A multi-period view of the public annual-account figures reported for Farmave, with comparable measures and links to available source documents.
Company overviewRegistry number
0770922148
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for Farmave
2025 versus 2024
- Operating line
- €61,401
- EBITDA
- €58,513
- Total assets
- €636,950
- Equity
- €64,300
-6.4%
-8.5%
+52.6%
-8%
EBITDA margin +95.3% · Equity ratio +10.1%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €61,401 | €58,513 | €636,950 | €64,300 | - |
| 202431 Dec 2024 | €65,569 | €63,918 | €417,343 | €69,903 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.